重新审视结肠镜检查后结直肠癌风险:内镜医师操作表现与高危息肉存在的比较
该研究基于荷兰结直肠癌筛查计划中2014至2020年因粪便免疫化学检测阳性而行的结肠镜检查数据,纳入239,217人,分析3年内结肠镜检查后结直肠癌(PCCRC)风险与高危息肉及内镜医师腺瘤检出率(ADR)或近端锯齿状息肉检出率(PSPDR)的关系。结果显示,高危息肉的存在与PCCRC风险无关(HR 1.00),而ADR和PSPDR每增加一点分别与PCCRC风险降低相关(HR 0.94和0.92)。结论认为PCCRC风险主要受内镜医师操作表现影响,而非高危息肉的存在。
要点
- 高危息肉的存在与3年内PCCRC风险无关(HR 1.00;95%CI 0.75-1.35)。
- ADR每增加一点,PCCRC风险HR为0.94(95%CI 0.92-0.96);PSPDR每增加一点,HR为0.92(95%CI 0.89-0.95)。
- 无/低风险息肉但由低ADR内镜医师检查者,PCCRC的HR为2.11(95%CI 1.21-3.65),对照为高风险息肉但由高ADR内镜医师检查者。
核心结论
- 个体初始数年的PCCRC风险主要受内镜医师操作表现影响,而非高危息肉的存在。
- 为减少PCCRC,除确保适当的监测间隔外,监测和审计内镜医师质量指标至关重要。
研究设计与样本
- 研究使用2014至2020年荷兰结直肠癌筛查计划中因粪便免疫化学检测阳性而行的结肠镜检查数据。
- 共纳入239,217人,其中74,289人在基线切除高危息肉,202人在随后3年内发生PCCRC。
- 采用Cox比例风险回归分析3年PCCRC风险与高危息肉存在及ADR或PSPDR的关联,并将内镜医师按ADR和PSPDR分为低/中/高三组进行分层分析。
主要发现
- 高危息肉的存在与PCCRC风险无关(HR 1.00;95%CI 0.75-1.35)。
- ADR每增加一点与PCCRC风险降低相关(HR 0.94;95%CI 0.92-0.96)。
- PSPDR每增加一点与PCCRC风险降低相关(HR 0.92;95%CI 0.89-0.95)。
- 无/低风险息肉但由低ADR内镜医师检查者,与高风险息肉但由高ADR内镜医师检查者相比,PCCRC的HR为2.11(95%CI 1.21-3.65)。
临床怎么用
- 原文结论认为,为减少PCCRC,除确保适当的监测间隔外,监测和审计内镜医师质量指标至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current post-polypectomy guidelines set intervals based solely on features of resected polyps. Despite the well-known inverse relationship between both adenoma detection rate (ADR) and proximal serrated polyp detection rate (PSPDR) with post-colonoscopy colorectal cancers (PCCRCs), both quality indicators are not considered when determining surveillance intervals. METHODS: We used colonoscopy data from 2014 to 2020 performed for a positive fecal immunochemical test in the Dutch colorectal cancer screening program. Individuals were categorized into having high-risk polyps or no/low-risk polyps resected. The association between 3-year PCCRC-risk and presence of high-risk polyps and either ADR or PSPDR was studied with Cox proportional hazard regression. Secondly, endoscopists were categorized into low/medium/high ADR and PSPDR to enable stratified analysis. RESULTS: A total of 239,217 individuals were included; 74,289 had high-risk polyps resected at baseline and 202 had PCCRC within the subsequent 3 years. Presence of high-risk polyps was not associated with PCCRC-risk (hazard ratio [HR], 1.00; 95% confidence interval [CI], 0.75-1.35), whereas ADR and PSPDR showed a strong association with PCCRC (per point increase HR, 0.94; 95% CI, 0.92-0.96; HR, 0.92; 95% CI, 0.89-0.95, respectively). For individuals with no/low-risk polyps but examined by endoscopists with low ADR, the HR of PCCRC was 2.11 (95% CI, 1.21-3.65), as compared with individuals with high-risk polyps but examined by endoscopists with high ADR. CONCLUSIONS: An individual's PCCRC risk in the initial years is primarily influenced by endoscopist performance, rather than the presence of high-risk polyps. To reduce PCCRCs, besides ensuring appropriate surveillance intervals, it is crucial to monitor and audit endoscopist quality indicators.
引用
- van Roermund NS, Coupé VMH, Spaander MCW, et al. Rethinking Post-colonoscopy Colorectal Cancer Risk: Endoscopist Performance Versus Presence of High-risk Polyps. Clin Gastroenterol Hepatol. 2025. PMID: 40381870. doi:10.1016/j.cgh.2025.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。